Abstract
Photodynamic therapy (PDT) combines a drug or photosensitizer with a specific type of light to eradicate cancer cells. The cellular damage induced by PDT leads to activation of the DNA damage repair, which is an important factor for modulating tumor sensitivity to this treatment. β-Glucans bind complement receptor 3 on the effector cells, thereby activating them to kill tumor cells during PDT. Here, the hypothesis that adjuvant therapy with β-glucans would increase the efficacy of PDT resulting in pronounced necrosis of PDT-treated tumors and suppression of the DNA damage repair system is discussed.
Keywords: Immunotherapy, photodynamic therapy, tumor, cancer, glucan, photosensitizer, PDT, complement, CR3, cytotoxicity, NK cells, DNA, damage, repair, PCNA, anti-angiogenetic, inflammatory, response, treatment, lung carcinoma, necrosis, phagocytosis, mice.
Related Books
Advances in Physicochemical Properties of Biopolymers (Part 1)
Advances in Physicochemical Properties of Biopolymers (Part 2)
Biochemical Mechanisms of Aluminium Induced Neurological Disorders
Biochemistry: Fundamentals and Bioenergetics
Biology and Chemistry of Beta Glucan Vol: 1 Beta Glucans - Mechanisms of Action
Cutting Edge Techniques in Biophysics, Biochemistry and Cell Biology: From Principle to Applications
Essential Techniques for Medical and Life Scientists: A Guide to Contemporary Methods and Current Applications with the Protocols: Part I
Essential Techniques for Medical and Life Scientists: A Guide to Contemporary Methods and Current Applications- Part II
Evaluation of Cellular Processes by In Vitro Assays
Free Radical Biomedicine: Principles, Clinical Correlations, and Methodologies